As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Unintentional weight loss, shakes and tremors, heart palpitations, and heat intolerance are among some of the telltale signs ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

To manage these symptoms, women often seek remedies that range from lifestyle changes to wellness teas to even medications.

More than 500,000 people in the UK are now taking weight-loss injections, with the majority coming from private pharmacies.

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

It is a fair bet to guess that many people taking drugs such as Ozempic are just tired of being fat. The hitch with Ozempic, ...